Reduced levels of L1 promoter methylation along with increased DNA methyltransferase (DNMT)3B, DNMT1 and MeCp2, but reduced LSH levels were detected in SS-low risk patients compared to both SS-lymphoma and sicca controls. The gene discussed is MECP2; the disease is lymphoma.